{"id":759502,"title":"Recommendation on the Use of Live Attenuated Influenza Vaccine (LAIV) in HIV-Infected Individuals - Canada.ca","sourceCode":"phac","sourceName":"Public Health Agency of Canada","language":"en","captureDate":"2026-02-25","captureTimestamp":"2026-02-25T18:47:27.548000+00:00","jobId":7,"originalUrl":"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/live-attenuated-influenza-vaccine-hiv-infected-individuals.html","snippet":"Recommendation on the Use of Live Attenuated Influenza Vaccine (LAIV) in HIV-Infected Individuals An Advisory Committee Statement (ACS) | National Advisory Committee on Immunization (NACI) Preamble The National Advisory Committee on Immunization (NACI) provides the Public Health…","rawSnapshotUrl":"/api/snapshots/raw/759502","browseUrl":"https://replay.healtharchive.ca/job-7/20260225184727/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/live-attenuated-influenza-vaccine-hiv-infected-individuals.html#ha_snapshot=759502","mimeType":"text/html","statusCode":200,"captureBackend":"playwright_warc","captureFidelity":"fallback"}